In a meta-analysis with an average BRAF mutation prevalence of 47.8% in the included melanoma studies, the risk of death was 1.7 times higher in patients with BRAF mutant melanoma than in patients with BRAF wild-type melanoma [5]. This evidence concerns the gene BRAF and melanoma.